Annual EBITDA
-$102.48 M
-$50.20 M-96.01%
December 31, 2023
Summary
- As of February 28, 2025, GPCR annual EBITDA is -$102.48 million, with the most recent change of -$50.20 million (-96.01%) on December 31, 2023.
- During the last 3 years, GPCR annual EBITDA has fallen by -$86.57 million (-544.29%).
- GPCR annual EBITDA is now -544.29% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$45.57 M
-$12.49 M-37.74%
September 30, 2024
Summary
- As of February 28, 2025, GPCR quarterly EBITDA is -$45.57 million, with the most recent change of -$12.49 million (-37.74%) on September 30, 2024.
- Over the past year, GPCR quarterly EBITDA has dropped by -$19.50 million (-74.83%).
- GPCR quarterly EBITDA is now -261.19% below its all-time high of -$12.62 million, reached on September 30, 2022.
Performance
GPCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$141.37 M
-$19.50 M-16.01%
September 30, 2024
Summary
- As of February 28, 2025, GPCR TTM EBITDA is -$141.37 million, with the most recent change of -$19.50 million (-16.01%) on September 30, 2024.
- Over the past year, GPCR TTM EBITDA has dropped by -$56.93 million (-67.42%).
- GPCR TTM EBITDA is now -970.34% below its all-time high of -$13.21 million, reached on December 1, 2021.
Performance
GPCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GPCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.0% | -74.8% | -67.4% |
| 3 y3 years | -544.3% | -74.8% | -67.4% |
| 5 y5 years | -544.3% | -74.8% | -67.4% |
GPCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -172.4% | at low | -261.2% | at low | -970.3% | at low |
| 5 y | 5-year | -544.3% | at low | -261.2% | at low | -970.3% | at low |
| alltime | all time | -544.3% | at low | -261.2% | at low | -970.3% | at low |
Structure Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$45.57 M(+37.7%) | -$141.37 M(+16.0%) |
| Jun 2024 | - | -$33.08 M(+4.1%) | -$121.86 M(+6.3%) |
| Mar 2024 | - | -$31.79 M(+2.8%) | -$114.69 M(+11.9%) |
| Dec 2023 | -$102.48 M(+96.0%) | -$30.92 M(+18.6%) | -$102.48 M(+21.4%) |
| Sep 2023 | - | -$26.07 M(+0.6%) | -$84.44 M(+18.9%) |
| Jun 2023 | - | -$25.91 M(+32.4%) | -$70.99 M(+20.4%) |
| Mar 2023 | - | -$19.58 M(+52.0%) | -$58.98 M(+12.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$52.28 M(+39.0%) | -$12.88 M(+2.1%) | -$52.28 M(-0.6%) |
| Sep 2022 | - | -$12.62 M(-9.2%) | -$52.61 M(+31.5%) |
| Jun 2022 | - | -$13.90 M(+7.9%) | -$39.99 M(+53.3%) |
| Mar 2022 | - | -$12.88 M(-2.5%) | -$26.09 M(+97.5%) |
| Dec 2021 | -$37.62 M(+136.5%) | - | - |
| Dec 2021 | - | -$13.21 M | -$13.21 M |
| Dec 2020 | -$15.91 M | - | - |
FAQ
- What is Structure Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Structure Therapeutics?
- What is Structure Therapeutics annual EBITDA year-on-year change?
- What is Structure Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Structure Therapeutics?
- What is Structure Therapeutics quarterly EBITDA year-on-year change?
- What is Structure Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Structure Therapeutics?
- What is Structure Therapeutics TTM EBITDA year-on-year change?
What is Structure Therapeutics annual EBITDA?
The current annual EBITDA of GPCR is -$102.48 M
What is the all time high annual EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high annual EBITDA is -$15.91 M
What is Structure Therapeutics annual EBITDA year-on-year change?
Over the past year, GPCR annual EBITDA has changed by -$50.20 M (-96.01%)
What is Structure Therapeutics quarterly EBITDA?
The current quarterly EBITDA of GPCR is -$45.57 M
What is the all time high quarterly EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high quarterly EBITDA is -$12.62 M
What is Structure Therapeutics quarterly EBITDA year-on-year change?
Over the past year, GPCR quarterly EBITDA has changed by -$19.50 M (-74.83%)
What is Structure Therapeutics TTM EBITDA?
The current TTM EBITDA of GPCR is -$141.37 M
What is the all time high TTM EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high TTM EBITDA is -$13.21 M
What is Structure Therapeutics TTM EBITDA year-on-year change?
Over the past year, GPCR TTM EBITDA has changed by -$56.93 M (-67.42%)